Triple

T22457028
Position Surface form Disambiguated ID Type / Status
Subject ICH E8 General Considerations for Clinical Trials E555142 entity
Predicate abbreviation P43 FINISHED
Object ICH E8 — NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: ICH E8 | Statement: [ICH E8 General Considerations for Clinical Trials, abbreviation, ICH E8]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: ICH E8
Context triple: [ICH E8 General Considerations for Clinical Trials, abbreviation, ICH E8]
  • A. ICH E2D
    ICH E2D is an International Council for Harmonisation guideline that provides standards for post-approval safety data management, including the collection, evaluation, and reporting of safety information for marketed medicinal products.
  • B. E8
    E8 is an airport departure gate located within Concourse E.
  • C. E8
    E8 is an exceptional, highly symmetric Lie group of rank 8 that plays a central role in advanced gauge theories and string theory.
  • D. ICH E2A
    ICH E2A is an International Council for Harmonisation guideline that standardizes clinical safety data management and expedited reporting of adverse drug reactions in clinical trials.
  • E. ICH E2C
    ICH E2C is an International Council for Harmonisation guideline that defines standards for the periodic safety update reporting of medicinal products to support ongoing pharmacovigilance and risk management.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: ICH E8
Target entity description: ICH E8 is an International Council for Harmonisation guideline that outlines fundamental principles and general considerations for the design, conduct, and quality of clinical trials.
  • A. ICH E2D
    ICH E2D is an International Council for Harmonisation guideline that provides standards for post-approval safety data management, including the collection, evaluation, and reporting of safety information for marketed medicinal products.
  • B. E8
    E8 is an airport departure gate located within Concourse E.
  • C. E8
    E8 is an exceptional, highly symmetric Lie group of rank 8 that plays a central role in advanced gauge theories and string theory.
  • D. ICH E2A
    ICH E2A is an International Council for Harmonisation guideline that standardizes clinical safety data management and expedited reporting of adverse drug reactions in clinical trials.
  • E. ICH E2C
    ICH E2C is an International Council for Harmonisation guideline that defines standards for the periodic safety update reporting of medicinal products to support ongoing pharmacovigilance and risk management.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e51fdec8190adfdf9f8a6362221 completed April 16, 2026, 5:37 p.m.
NER Named-entity recognition batch_69f15b7c428c8190847a259eef969525 completed April 29, 2026, 1:14 a.m.
Created at: April 16, 2026, 8:48 p.m.